Brainsway Stock Fundamentals
| BWAY Stock | ILA 1,829 41.00 2.19% |
Brainsway fundamentals help investors to digest information that contributes to Brainsway's financial success or failures. It also enables traders to predict the movement of Brainsway Stock. The fundamental analysis module provides a way to measure Brainsway's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Brainsway stock.
Brainsway |
Brainsway Company Operating Margin Analysis
Brainsway's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Brainsway Operating Margin | (0.29) % |
Most of Brainsway's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brainsway is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Brainsway has an Operating Margin of -0.2876%. This is 99.18% lower than that of the Healthcare sector and 99.27% lower than that of the Medical Devices industry. The operating margin for all Israel stocks is 94.78% lower than that of the firm.
Brainsway Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brainsway's current stock value. Our valuation model uses many indicators to compare Brainsway value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brainsway competition to find correlations between indicators driving Brainsway's intrinsic value. More Info.Brainsway is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Brainsway by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Brainsway's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Brainsway Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Brainsway's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Brainsway could also be used in its relative valuation, which is a method of valuing Brainsway by comparing valuation metrics of similar companies.Brainsway is currently under evaluation in operating margin category among its peers.
Brainsway Fundamentals
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0751 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | (0.29) % | |||
| Current Valuation | (85.93 M) | |||
| Shares Outstanding | 33.08 M | |||
| Shares Owned By Insiders | 19.83 % | |||
| Shares Owned By Institutions | 1.11 % | |||
| Price To Book | 0.65 X | |||
| Price To Sales | 3.76 X | |||
| Revenue | 29.66 M | |||
| Gross Profit | 24.35 M | |||
| EBITDA | (3.31 M) | |||
| Net Income | (6.46 M) | |||
| Cash And Equivalents | 55.87 M | |||
| Cash Per Share | 1.73 X | |||
| Total Debt | 672 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 9.26 X | |||
| Book Value Per Share | 1.46 X | |||
| Cash Flow From Operations | 884 K | |||
| Earnings Per Share | (0.22) X | |||
| Target Price | 14.0 | |||
| Number Of Employees | 118 | |||
| Beta | 0.2 | |||
| Market Capitalization | 116.06 M | |||
| Total Asset | 75.73 M | |||
| Net Asset | 75.73 M |
About Brainsway Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brainsway's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainsway using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainsway based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. BRAINSWAY operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 100 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Brainsway Stock
When determining whether Brainsway offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainsway's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainsway. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Brainsway Stock refer to our How to Trade Brainsway Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.